Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
Guardado en:
Autores principales: | Jean-Pierre Van Geertruyden, Pierre Van Damme, Ynke Larivière, Vivi Maketa, Junior Matangila, Patrick Mitashi, Jessie De Bie, Trésor Zola, Elke Stoppie, Hypolite Muhindo-Mavoko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ab5033e4ccb40efbb012094069c25e3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
por: Ros Chapman, et al.
Publicado: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Andrew Chak-Yiu Lee, et al.
Publicado: (2021) -
Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
por: Alexandra J. Spencer, et al.
Publicado: (2021) -
Prophylactic Control of Mycoplasma Contamination in Starting Biological Materials Used in Viral Vaccine Production
por: Ahmed F. Soudy
Publicado: (2019) -
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
por: Jing Cai, et al.
Publicado: (2021)